Wintrust Investments LLC increased its position in CVS Health Corp (NYSE:CVS) by 15.2% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 9,820 shares of the pharmacy operator’s stock after buying an additional 1,296 shares during the period. Wintrust Investments LLC’s holdings in CVS Health were worth $535,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of the company. Parallel Advisors LLC raised its position in shares of CVS Health by 6.8% in the second quarter. Parallel Advisors LLC now owns 19,116 shares of the pharmacy operator’s stock valued at $1,041,000 after buying an additional 1,215 shares during the last quarter. Investment House LLC raised its position in shares of CVS Health by 43.5% in the second quarter. Investment House LLC now owns 39,989 shares of the pharmacy operator’s stock valued at $2,179,000 after buying an additional 12,119 shares during the last quarter. CIBC Asset Management Inc raised its position in shares of CVS Health by 13.5% in the second quarter. CIBC Asset Management Inc now owns 629,693 shares of the pharmacy operator’s stock valued at $34,312,000 after buying an additional 75,027 shares during the last quarter. Sullivan Bruyette Speros & Blaney LLC raised its position in shares of CVS Health by 3.6% in the second quarter. Sullivan Bruyette Speros & Blaney LLC now owns 6,476 shares of the pharmacy operator’s stock valued at $353,000 after buying an additional 228 shares during the last quarter. Finally, Nichols & Pratt Advisers LLP MA raised its position in shares of CVS Health by 3.4% in the second quarter. Nichols & Pratt Advisers LLP MA now owns 222,646 shares of the pharmacy operator’s stock valued at $12,141,000 after buying an additional 7,404 shares during the last quarter. 75.20% of the stock is owned by institutional investors and hedge funds.

A number of equities analysts have recently weighed in on CVS shares. UBS Group cut their price objective on shares of CVS Health from $74.00 to $67.00 and set a “sell” rating for the company in a research report on Thursday, May 2nd. BMO Capital Markets set a $63.00 price objective on shares of CVS Health and gave the company a “hold” rating in a research report on Friday, May 3rd. Mizuho set a $71.00 price objective on shares of CVS Health and gave the company a “buy” rating in a research report on Wednesday, June 5th. ValuEngine lowered shares of CVS Health from a “sell” rating to a “strong sell” rating in a research report on Tuesday, July 2nd. Finally, Standpoint Research raised shares of CVS Health from a “hold” rating to a “buy” rating in a research report on Wednesday, June 5th. Two analysts have rated the stock with a sell rating, seven have given a hold rating, sixteen have assigned a buy rating and one has assigned a strong buy rating to the company. CVS Health has an average rating of “Buy” and an average target price of $75.14.

Shares of CVS Health stock traded up $0.50 during trading hours on Wednesday, hitting $62.06. The company’s stock had a trading volume of 195,778 shares, compared to its average volume of 8,907,550. CVS Health Corp has a 1-year low of $51.72 and a 1-year high of $82.15. The business has a fifty day moving average of $56.93 and a 200 day moving average of $56.39. The company has a market capitalization of $78.39 billion, a PE ratio of 8.76, a P/E/G ratio of 1.32 and a beta of 0.90. The company has a quick ratio of 0.64, a current ratio of 0.95 and a debt-to-equity ratio of 1.39.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Wednesday, August 7th. The pharmacy operator reported $1.89 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.70 by $0.19. CVS Health had a net margin of 1.91% and a return on equity of 16.15%. The company had revenue of $63.43 billion during the quarter, compared to analyst estimates of $62.66 billion. During the same quarter in the prior year, the business earned $1.69 earnings per share. The business’s quarterly revenue was up 35.2% compared to the same quarter last year. On average, sell-side analysts anticipate that CVS Health Corp will post 6.96 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which was paid on Friday, August 2nd. Stockholders of record on Thursday, July 25th were given a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 3.22%. The ex-dividend date was Wednesday, July 24th. CVS Health’s payout ratio is currently 28.25%.

About CVS Health

CVS Health Corporation provides health services and plans in the United States. Its Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, Medicare Part D, clinical, disease management, and medical spend management services.

Further Reading: What is a put option?

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.